Short-term administration of JAK2 inhibitors reduces splenomegaly in mouse models of β-thalassemia intermedia and majorCarla Casu, Stefano Rivella, Vania Lo Presti et al.|Haematologica|2017Cited by 33
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathiesLaura Breda, Stefano Rivella, Carla Casu et al.|Molecular Therapy|2021Cited by 23
Vzhe-039, a Novel Structurally-Enhanced Allosteric Hemoglobin Effector Inhibits Sickling of SS Erythrocytes In Vitro, and Exhibits Improved Pharmacologic Properties In VivoMartin K. Safo, Osheiza Abdulmalik, Guoyan Xu et al.|Blood|2016Cited by 2
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalanceAlisa Dong, Laura Breda, Valentina Ghiaccio et al.|Haematologica|2020Cited by 2
PP-14, a Novel Structurally-Enhanced Antisickling Allosteric Hemoglobin Effector, Increases Oxygen Affinity and Disrupts Hemoglobin S Polymer FormationMartin K. Safo, Osheiza Abdulmalik, Piyusha P. Pagare et al.|Blood|2019Cited by 1